ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial
- DOI
- 10.1093/annonc/mdu189
- Published
- 2014-08
- Container
- Annals of Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/annonc/mdu189,
title = {ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial},
author = {N. Mounier and P. Brice and S. Bologna and J. Briere and I. Gaillard and M. Heczko and J. Gabarre and O. Casasnovas and J. Jaubert and P. Colin and A. Delmer and A. Devidas and E. Bachy and E. Nicolas-Virelizier and A. Aoudjhane and C. Humbrecht and M. Andre and P. Carde},
year = {2014},
journal = {Annals of Oncology},
doi = {10.1093/annonc/mdu189},
url = {https://doi.org/10.1093/annonc/mdu189}
}RIS
TY - JOUR TI - ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial AU - N. Mounier AU - P. Brice AU - S. Bologna AU - J. Briere AU - I. Gaillard AU - M. Heczko AU - J. Gabarre AU - O. Casasnovas AU - J. Jaubert AU - P. Colin AU - A. Delmer AU - A. Devidas AU - E. Bachy AU - E. Nicolas-Virelizier AU - A. Aoudjhane AU - C. Humbrecht AU - M. Andre AU - P. Carde PY - 2014 JO - Annals of Oncology DO - 10.1093/annonc/mdu189 UR - https://doi.org/10.1093/annonc/mdu189 ER -
APA
Mounier, N., Brice, P., Bologna, S., Briere, J., Gaillard, I., Heczko, M., Gabarre, J., Casasnovas, O., Jaubert, J., Colin, P., Delmer, A., Devidas, A., Bachy, E., Nicolas-Virelizier, E., Aoudjhane, A., Humbrecht, C., Andre, M., & Carde, P. (2014). ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial. Annals of Oncology. https://doi.org/10.1093/annonc/mdu189
Source records
- crossref · retrieved 2026-09-26T15:53:53.292Z